scorecardresearch
Tuesday, August 26, 2025
TopicDCGI

Topic: DCGI

After WHO alert, drug controller general warns against use of cough syrups containing pholcodine

Pholcodine is used to treat dry cough. WHO had flagged risk of anaphylactic reactions in those who took remedies containing Pholcodine at least 12 months prior to surgery.

‘1st for India’ — device made from pig gall bladder heals skin wounds like burns with few scars

Low-cost tissue-engineering scaffold Cholederm — developed by Thiruvananthapuram-based Sree Chitra Tirunal Institute for Medical Sciences & Technology — approved by DCGI.

All about Serum Institute’s HPV vaccine, India’s 1st indigenous shot against cervical cancer

Pune-based SII has got the go-ahead from the Drugs Controller General of India to market the vaccine. Cervical cancer is one of the leading causes of female cancer mortality worldwide.

DCGI approves Corbevax as first heterologous Covid booster dose for adults

A press release from Corbevax maker said it could be administered as a booster after six months of administration of primary vaccination for restricted use in emergency situation.

DCGI gives nod to Biological E’s Covid vaccine phase 2/3 clinical trials on 5-18 year olds

The trial will be conducted across 10 sites in India. Zydus Cadila's ZyCoV-D is so far the only vaccine to get Emergency Use Authorisation in the 12-18 years age group in India.

Zydus Cadila applies for approval to ZyCov-D, India’s 1st Covid vaccine tested on 12-18-yr-olds

If ZyCov-D gets the approval, it will be the fifth vaccine authorised for use in India after Covishield, Covaxin, Sputnik V and Moderna.

Drug regulator says no need for bridging trials on foreign approved vaccines before India roll out

DCGI modifies earlier order on emergency approval of well-established vaccines, waives several requirements, but retains assessment of first 100 beneficiaries before proper roll out.

DCGI approves anti-Covid drug developed by DRDO for emergency use

The drug has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of DRDO, in collaboration with Dr Reddy's Laboratories in Hyderabad.

DCGI to take decision on emergency use applications for foreign Covid vaccines in 3 days

The DCGI will issue permission for restricted emergency use on the condition that the vaccine be used according to guidelines under the National Covid-19 Vaccination Programme.

DCGI approves Russian Covid vaccine Sputnik for restricted emergency use in India

Sputnik V is to be administered intramuscularly to individuals aged 18 yrs & above in two doses of 0.5 ml each with an interval of 21 days.

On Camera

India will absorb Trump tariff impact due to its Achilles’ heel

Like China, India remains a big domestic market, which will continue to attract investment, but the US tariffs will make India unattractive for future investments.

New insolvency frameworks to shorter timelines, how 2025 amendment bill proposes to transform IBC

New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.

Was Pahalgam a trap by Pakistan to lure India into a conflict? An Army officer thinks so

Speaking at tri-service seminar, Major General SP Vishwasrao also said farmers’ protest, anti-CAA agitation & situation in Manipur was part of ‘larger ploy’ to destabilise India.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.